Vycor Medical, Inc. (OTCMKTS:VYCO) Sees Large Decline in Short Interest

Vycor Medical, Inc. (OTCMKTS:VYCO) was the recipient of a large drop in short interest in May. As of May 29th, there was short interest totaling 7,489 shares, a drop of 34.2% from the May 14th total of 11,389 shares. Based on an average daily volume of 13,377 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.0% of the company’s stock are sold short.

Vycor Medical Stock Performance

VYCO stock opened at $0.07 on Thursday. The stock’s 50 day moving average is $0.07 and its two-hundred day moving average is $0.10. Vycor Medical has a 52-week low of $0.03 and a 52-week high of $0.20.

Vycor Medical Company Profile

Vycor Medical, Inc is a medical device company specializing in the design, development and manufacture of minimally invasive cranial access systems for use in neurosurgery. The company’s proprietary endoport platform is engineered to provide neurosurgeons with controlled, cannula-based access for intracranial procedures such as tumor biopsy, resection and hematoma drainage. By integrating visualization channels and atraumatic retraction technology, Vycor’s products are intended to reduce collateral damage to healthy brain tissue and streamline procedural workflows.

The company’s core portfolio includes its flagship endoport system along with complementary accessories such as obturators, sheaths and closure devices.